Fifteen Years' Experience of Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Children and Adolescents: Evaluation of Different Techniques.

Mohamed Abdel-Aziz, Muhammad Abdelhafez Mahmoud, M. Daboos, M. Abdelmaboud, M. Akl, Mohamed Mahfouz, Ahmed Salama, Yasser Ashour, Yousef Mohamed, Mohamed Hussien, Ahmed Azab, Mohamed Magid
{"title":"Fifteen Years' Experience of Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Children and Adolescents: Evaluation of Different Techniques.","authors":"Mohamed Abdel-Aziz, Muhammad Abdelhafez Mahmoud, M. Daboos, M. Abdelmaboud, M. Akl, Mohamed Mahfouz, Ahmed Salama, Yasser Ashour, Yousef Mohamed, Mohamed Hussien, Ahmed Azab, Mohamed Magid","doi":"10.1089/lap.2024.0026","DOIUrl":null,"url":null,"abstract":"Background: Thoracoscopic sympathetic chain interruption is a definitive and effective therapy for severe primary palmar hyperhidrosis (PPH). Well-known methods include sympathectomy, sympathotomy, and clipping, but the occurrence of compensatory sweating offsets these methods. This study aims to report our experience with thoracoscopic sympathetic chain interruption in a large group of patients of age <18 years with PPH, focusing on surgical outcomes, complication rates, and patient satisfaction. Patients and Methods: This retrospective study included patients who underwent thoracoscopic sympathectomy, sympathotomy, or clipping for severe PPH between April 2008 and March 2023 at the Pediatric Surgery Department, Al-Azhar University Hospitals. Demographic and clinical data, operative steps, postoperative outcomes, complications, and patient satisfaction were reviewed from the patients' medical records. Results: During the 15-year study period, 420 children with PPH underwent bilateral thoracoscopic sympathetic chain interruption by either sympathectomy, sympathotomy, or clipping, with a sex ratio of 60% being females. The mean ages were 12 ± 3.48, 13 ± 2.45, and 13 ± 2.45 years, respectively. Sympathectomy was performed in 190 patients (45.2%), sympathotomy in 170 patients (40.5%), and clipping in 60 patients (14.3%). All patients had completed follow-up, with mean periods of ∼43 ± 5 months, 45 ± 3 months, and 42 ± 6 months, respectively. Complete palmar dryness was achieved in 405 patients (overall 96.4%) (97.8% after sympathectomy, 97.05% after sympathotomy, and 90% after clipping), whereas 2.1%, 2.9%, and 10% of patients experienced symptom recurrence, respectively, denoting significant statistical differences. Overall, 94 patients (22.4%) experienced compensatory sweating. Eventually, 409 patients (97.4%) were satisfied with the outcome, whereas 11 patients (2.6%) reported dissatisfaction, yet no significant differences found. Conclusion: The presented three modalities of thoracoscopic sympathetic chain interruption for PPH in children and adolescents are safe and effective, with overall very high postoperative satisfaction, despite a relatively high rate of compensatory sweating in sympathectomy group. Other major complications in this age population were scanty.","PeriodicalId":508448,"journal":{"name":"Journal of laparoendoscopic & advanced surgical techniques. Part A","volume":"22 S1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of laparoendoscopic & advanced surgical techniques. Part A","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/lap.2024.0026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Thoracoscopic sympathetic chain interruption is a definitive and effective therapy for severe primary palmar hyperhidrosis (PPH). Well-known methods include sympathectomy, sympathotomy, and clipping, but the occurrence of compensatory sweating offsets these methods. This study aims to report our experience with thoracoscopic sympathetic chain interruption in a large group of patients of age <18 years with PPH, focusing on surgical outcomes, complication rates, and patient satisfaction. Patients and Methods: This retrospective study included patients who underwent thoracoscopic sympathectomy, sympathotomy, or clipping for severe PPH between April 2008 and March 2023 at the Pediatric Surgery Department, Al-Azhar University Hospitals. Demographic and clinical data, operative steps, postoperative outcomes, complications, and patient satisfaction were reviewed from the patients' medical records. Results: During the 15-year study period, 420 children with PPH underwent bilateral thoracoscopic sympathetic chain interruption by either sympathectomy, sympathotomy, or clipping, with a sex ratio of 60% being females. The mean ages were 12 ± 3.48, 13 ± 2.45, and 13 ± 2.45 years, respectively. Sympathectomy was performed in 190 patients (45.2%), sympathotomy in 170 patients (40.5%), and clipping in 60 patients (14.3%). All patients had completed follow-up, with mean periods of ∼43 ± 5 months, 45 ± 3 months, and 42 ± 6 months, respectively. Complete palmar dryness was achieved in 405 patients (overall 96.4%) (97.8% after sympathectomy, 97.05% after sympathotomy, and 90% after clipping), whereas 2.1%, 2.9%, and 10% of patients experienced symptom recurrence, respectively, denoting significant statistical differences. Overall, 94 patients (22.4%) experienced compensatory sweating. Eventually, 409 patients (97.4%) were satisfied with the outcome, whereas 11 patients (2.6%) reported dissatisfaction, yet no significant differences found. Conclusion: The presented three modalities of thoracoscopic sympathetic chain interruption for PPH in children and adolescents are safe and effective, with overall very high postoperative satisfaction, despite a relatively high rate of compensatory sweating in sympathectomy group. Other major complications in this age population were scanty.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胸腔镜交感神经链阻断术治疗儿童和青少年手掌多汗症十五年的经验:对不同技术的评估。
背景:胸腔镜交感神经链阻断术是治疗严重原发性手掌多汗症(PPH)的有效方法。众所周知的方法包括交感神经切除术、交感神经切断术和剪切术,但代偿性出汗的发生抵消了这些方法的效果。本研究旨在报告我们在一大批年龄小于 18 岁的 PPH 患者中采用胸腔镜交感神经链阻断术的经验,重点关注手术效果、并发症发生率和患者满意度。患者和方法:这项回顾性研究纳入了2008年4月至2023年3月期间在爱资哈尔大学医院小儿外科接受胸腔镜交感神经切除术、交感神经切断术或剪切术治疗重度PPH的患者。我们从患者的病历中查阅了他们的人口统计学和临床数据、手术步骤、术后效果、并发症和患者满意度。研究结果在15年的研究期间,共有420名PPH患儿通过交感神经切除术、交感神经切断术或剪切术接受了双侧胸腔镜交感神经链阻断术,其中女性占60%。平均年龄分别为(12±3.48)岁、(13±2.45)岁和(13±2.45)岁。190名患者(45.2%)接受了交感神经切除术,170名患者(40.5%)接受了交感神经切断术,60名患者(14.3%)接受了剪切术。所有患者都完成了随访,平均随访时间分别为43±5个月、45±3个月和42±6个月。405名患者(总体为96.4%)实现了手掌完全干燥(交感神经切除术后为97.8%,交感神经切断术后为97.05%,剪切术后为90%),而分别有2.1%、2.9%和10%的患者症状复发,统计学差异显著。总体而言,94 名患者(22.4%)出现了代偿性出汗。最终,409 名患者(97.4%)对治疗结果表示满意,11 名患者(2.6%)表示不满意,但没有发现明显差异。结论这三种胸腔镜交感神经链阻断术治疗儿童和青少年 PPH 安全有效,尽管交感神经切除术组的代偿性出汗率相对较高,但术后总体满意度非常高。该年龄段人群的其他主要并发症很少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Don't Fear the Bleed: Assessing Postoperative Bleeding Incidence After Instituting a Standardized Prophylactic Heparin Protocol in Bariatric Patients. Video-Assisted Thoracoscopic Surgery Is a Safe and Feasible Technique for Mediastinal Parathyroid Lesions. We Reduced the Incidence of Postoperative Complications in Neonatal Ostomy Patients by Using Simple Devices. Is 3D Volumetric Evaluation Consistent with Postoperative Renal Parenchymal Preservation in Open and Robot-Assisted Laparoscopic Partial Nephrectomy? Biocompatible Cable Ties Are an Alternative to Metal Stabilizers for Bar Securement During Minimally Invasive Pectus Excavatum Repair.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1